EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Clinical translation of pluripotent stem cell-based therapies: successes and challenges

Josefine Rågård Christiansen iD, Agnete Kirkeby iD

Development · 2024-04-01 · 151 (7)

DOI: 10.1242/dev.202067 ↗

At a glance

Journal article in Development, published online on 2024-04-02. Written by Josefine Rågård Christiansen and 1 co-authors. Institution: Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), University of Copenhagen, 2200 Copenhagen N, Denmark. Major MEDLINE topics: Pluripotent Stem Cells. Cited 28 times so far (Crossref); 104 references. The full text is freely available (open access, CC BY 4.0). Funded by: Horizon 2020 Framework Programme, Novo Nordisk Foundation, Knut och Alice Wallenbergs Stiftelse.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The translational stem cell research field has progressed immensely in the past decade. Development and refinement of differentiation protocols now allows the generation of a range of cell types, such as pancreatic β-cells and dopaminergic neurons, from human pluripotent stem cells (hPSCs) in an efficient and good manufacturing practice-compliant fashion. This has led to the initiation of several clinical trials using hPSC-derived cells to replace lost or dysfunctional cells, demonstrating evidence of both safety and efficacy. Here, we highlight successes from some of the hPSC-based trials reporting early signs of efficacy and discuss common challenges in clinical translation of cell therapies.

Subjects

MeSH terms (MEDLINE)

Pluripotent Stem CellsHumansCell LineCell DifferentiationCell- and Tissue-Based TherapyStem Cell Research

Author keywords

ATMPCell therapyClinical trialHuman pluripotent stem cellsTransplantation

Authors and institutions

  • Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), University of Copenhagen, 2200 Copenhagen N, Denmark.
  • Department of Neuroscience, University of Copenhagen, 2200 Copenhagen N, Denmark.
  • Wallenberg Center for Molecular Medicine, Department of Experimental Medical Science, Lund University, 221 84 Lund, Sweden.

ORCID profiles: Josefine Rågård Christiansen, Agnete Kirkeby

Funding

  • Horizon 2020 Framework Programme
  • Novo Nordisk Foundation
  • Knut och Alice Wallenbergs Stiftelse

Cite

APA

Christiansen, J. R., & Kirkeby, A. (2024). Clinical translation of pluripotent stem cell-based therapies: successes and challenges. Development, 151(7). https://doi.org/10.1242/dev.202067

Vancouver

Christiansen JR, Kirkeby A. Clinical translation of pluripotent stem cell-based therapies: successes and challenges. Development. 2024;151(7). doi:10.1242/dev.202067

BibTeX
@article{Christiansen2024,
  author = {Christiansen, Josefine Rågård and Kirkeby, Agnete},
  title = {Clinical translation of pluripotent stem cell-based therapies: successes and challenges},
  journal = {Development},
  year = {2024},
  volume = {151},
  number = {7},
  doi = {10.1242/dev.202067}
}
Start for free →